The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder-Reference-Cited by-同舟云学术

The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder

Published:2008-03 Issue:1-3 Volume:100 Page:60-69
ISSN:0920-9964
Container-title:Schizophrenia Research
language:en
Short-container-title:Schizophrenia Research

Author:

Byerly Matthew J.,Nakonezny Paul A.,Rush A. John

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference22 articles.

1. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions;Burnier;J. Hypertens.,2001

2. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia;Byerly;Psychiatry Res.,2005

3. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder;Byerly;J. Clin. Psychiatry,2005

4. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia;Byerly;Psychiatr. Serv.,2007

5. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia;Diaz;J. Psychiatry Neurosci.,2001

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding social risk factors in patients presenting to the emergency Department for Acute Heart Failure: A pilot study;The American Journal of Emergency Medicine;2024-10

2. Development and Validation of a Tool to Explore Attitudes Towards meDication adHErence Using a Novel Self-Reported QuestionnairE (ADHERE-7);Pharmacy;2024-07-18

3. Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Deep Learning Enabled Clinical Decision Support System for Personalized Depression Treatment Selection and Management;2024-06-25

4. Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Deep Learning Enabled Clinical Decision Support System for Personalized Depression Treatment Selection and Management;2024-06-13

5. Feasibility and acceptability of a mobile intervention for patients with psychosis following psychiatric hospitalization: A pilot randomized controlled trial.;Psychological Services;2024-06-06